Psilocybin vs escitalopram for depression, recent trial findings

   Rated 0 / 5 stars

Save

CPD for this activity

Educational Activities (EA)

0.5 hours

These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

Reviewing Performance (RP)

0.5 hours

These are activities that require reflection on feedback about your work.

Measuring Outcomes (MO)

0 hours

These are activities that use your work data to ensure quality results.

EA
0.5 mins

Educational Activities (EA)
These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

RP
0.5 mins

Reviewing Performance (RP)
These are activities that require reflection on feedback about your work.

MO
0 mins

Measuring Outcomes (MO)
These are activities that use your work data to ensure quality results.

Listen to the episode

Description

In this episode:

  • A recent study Prof David Nutt was involved in pitted psilocybin against escitalopram in a cleverly designed equipoise randomised controlled trial
  • Results showed very rapid improvement (days rather than weeks) of depression symptoms and significantly better scores in wellbeing and depression in patients given psilocybin
  • Whilst it is clear more studies are needed, there is growing interest in the use of psychedelic agents in the treatment of depression amongst younger and trainee psychiatrists, psychotherapists, and the general public
  • As GPs, we should be aware of developments in this area

 

Host: Dr David Lim, GP and Medical Educator

Total time: 32 mins

Guest: Prof David Nutt, Neuropsychopharmacologist

 

Last Updated: 16 Nov, 2021

Rate this podcast
Help your colleagues find podcasts they'll enjoy by rating this podcast out of five stars.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
A/Prof Daryl Cheng

A/Prof Daryl Cheng

RSV Prevention in Infants and Pregnant Women

Prof Jason Ong

Prof Jason Ong

STIs – Common and Tricky Cases

Dr Terri Foran

Dr Terri Foran

Role of Testosterone During Menopause - Evidence vs Hype

Dr Fiona Chan

Dr Fiona Chan

Vision and Driving Fitness: Key Insights for Health Practitioners

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Prof David Nutt

expert

Prof David Nutt

Neuropsychopharmacologist; Director of the Neuropsychopharmacology Unit; Division of Brain Sciences; Imperial College, London

Recent articles

Find your area of interest

Share this

You have completed the Educational Activities (EA) component of this activity.

Select ‘Confirm & claim CPD‘ to confirm you have engaged with this activity in its entirety and claim your CPD.

You will be taken to explore further CPD learning available to you.

Menopause and MHT

Multiple sclerosis vs antibody disease

Using SGLT2 to reduce cardiovascular death in T2D

Peripheral arterial disease